共 50 条
- [31] Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapyCANCER, 2007, 110 (01) : 47 - 55Krishnan, SunilRana, VishalJanjan, Nora A.Varadhachary, Gauri R.Abbruzzese, James L.Das, PrajnanDelclos, Marc E.Gould, Morris S.Evans, Douglas B.Wolff, Robert A.Crane, Christopher H.
- [32] Phase II study of oxaliplatin (OX), 5-fluorouracil (5-FU), and radiation therapy (RT) followed by gemcitabine (GEM) in patients with unresectable pancreatic cancerJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Kim, G. P.Haddock, M.Foster, N. R.Bollinger, J.Stella, P. J.Kugler, J. W.Alberts, S. R.Martenson, J.
- [33] Phase I/II study of gemcitabine plus S-1 with concurrent radiotherapy in patients of unresectable locally advanced pancreatic cancerJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)Ioka, TatsuyaKatayama, KazuhiroIshida, NobukoSueyoshi, HironariTakada, RyojiYamai, TakuoFukutake, NobuyasuAshida, ReikoAkita, HirofumiTakahashi, HidenoriKawaguchi, YoshifumiKonishi, KojiTeshima, Teruki
- [34] Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experienceCancer Chemotherapy and Pharmacology, 2015, 75 : 941 - 947Roberto PetrioliEdoardo FranciniFranco RovielloDaniele MarrelliAnna Ida FiaschiLetizia LaeraGiulia RossiV. BiancoS. BrozzettiGiandomenico Roviello
- [35] Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer - A phase I studyAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 570 - 575Iannitti, DDipetrillo, TAkerman, PBarnett, JMMaia-Acuna, CCruff, DMiner, TMartel, DCioffi, WRemis, MKennedy, TSafran, H
- [36] Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experienceCANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (05) : 941 - 947Petrioli, RobertoFrancini, EdoardoRoviello, FrancoMarrelli, DanieleFiaschi, Anna IdaLaera, LetiziaRossi, GiuliaBianco, V.Brozzetti, S.Roviello, Giandomenico
- [37] Phase II study of oxaliplatin (OHP) and protracted 5-fluorouracil (5FU) infusion in pretreated metastatic colorectal cancer (MCRC) patientsANNALS OF ONCOLOGY, 2000, 11 : 73 - 73Mini, EPinto, CAngelelli, BDentico, PPiana, ENobili, SGentile, ALScicolone, SMazzei, TMartoni, A
- [39] A phase II study of gemcitabine, oxaliplatin, and erlotinib (GEMOX-T) combination chemotherapy in previously untreated patients with locally advanced unresectable or metastatic pancreatic cancerJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Yun, JinaKim, Han JoKim, Kyoung HaKim, Se HyungKim, Hyun JungLee, Sang-CheolBae, Sang ByungKim, Chan KyuLee, NamsuLee, Kyu TaekPark, Soong KyuWon, Jong-HoHong, Dae SikPark, Hoe SookChoi, Hyun JongMoon, Jong Ho
- [40] Phase I Study of Definitive Chemoradiation With Cisplatin/5-FU Plus Cetuximab in Unresectable Esophageal CancerEUROPEAN JOURNAL OF CANCER, 2011, 47 : S450 - S450Rades, D.Moehler, M. H.Schmidberger, H.Fellermann, K.Buerk, C.